In Conversation with Jo Halliday – CEO, Talking Medicines

Talking through building & growing a data & AI company within pharma marketing & media

Solli
5th November 2024

In the penultimate ‘In Conversation With’ of 2024, Jo Halliday, CEO of Talking Medicines, joins solli CEO Richard Springham to discuss the journey of Talking Medicines – a data and AI company looking to shape the future of pharma marketing.

Together, they delve into the company’s heritage in data and AI, the impact of ChatGPT’s launch on the industry, and its ambitions for the future of pharma media.

In this exclusive interview, Jo and Richard explore:

  • The evolution of Talking Medicines
  • How AI breakthroughs are reshaping healthcare
  • The future role of AI in healthcare marketing

 

Solli

SIGN UP FOR FREE TODAY

Access your FREE my.solli account to get unlimited access to all FREE content across solli.
SIGN IN / SIGN UP
Most Popular Content